HOME › DRUGS › DIROXIMEL FUMARATE
ACTIVE SUBSTANCE / INN

DIROXIMEL FUMARATE

Brand name(s): DIROXIMEL FUMARATE, VUMERITY, Vumerity
FDA LISTED
EMA LISTED
PRESCRIPTION
AUTHORISED
ANDA218596
Multiple Sclerosis, Relapsing-Remitting
ACTIVE SUBSTANCE
Diroximel Fumarate
REGULATORS
FDA · EMA
SPONSORS / MAH
BIOGEN INC, ZYDUS, Biogen Netherlands B.V.
TOTAL APPLICATIONS
3
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
DIROXIMEL FUMARATEANDA218596ZYDUSPrescription
VUMERITYNDA211855BIOGEN INCPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
VumerityBiogen Netherlands B.V.Authorised15/11/2021Multiple Sclerosis, Relapsing-Remitting

FULL INTELLIGENCE ON DIROXIMEL FUMARATE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →